Search for: "Light v. Lang"
Results 81 - 100
of 192
Sort by Relevance
|
Sort by Date
17 Jan 2020, 8:56 am
Horizont’s UK patent (the ‘Patent’) claimed a board to be mounted on to vehicles which had an arrangement of lights which included flashing directional arrows and a warning cross which was shown in a different colour in a constant light. [read post]
13 Dec 2019, 12:42 am
Supreme Court in Graver Tank v. [read post]
5 Dec 2019, 12:59 am
As a result, several questions remain open, including: Will the opposition proceeding be oral (as are oppositions before the EPO), as suggested by the “oral debate” and the fact that the opposition will be decided “in the light of all written and oral observations” (Article R. 613-44-5), or will it be written (as it is customary in French civil proceedings, excluding summary proceedings)? [read post]
28 Oct 2019, 2:43 am
For instance, in Imar v. [read post]
15 Oct 2019, 7:43 am
Floyd LJ revisited the leading cases of Biogen v Medeva [1997] and Generics v Lundbeck [2009] on breadth of claim insufficiency. [read post]
11 Sep 2019, 1:00 pm
The Advocate General further attempts to shed light on the requirement that the two-part test of Teva v. [read post]
22 Aug 2019, 12:28 am
Sara MoranThe Court of Appeal allowed ZyXEL’s appeal, finding that in light of its waiver of its RAND licence rights, declaratory relief to determine the scope and terms of the licence which TQD was bound to offer to the two ZyXEL parties would no longer serve a useful purpose. [read post]
13 Aug 2019, 4:20 pm
In the light of the fact that it has remained unclear why Sisvel considers it necessary to anticipate the English or Dutch proceedings on the merits of the case, Xiaomi’s interests in a proper determination in a procedure with longer deadlines must be given serious consideration. [read post]
24 Jul 2019, 6:22 am
Legal background regarding Arrow-declarations The underlying jurisdiction was established in Arrow Generics v Merck & Co Inc [2007] FSR 39 and approved by the Court of Appeal in Fujifilm v AbbVie [2017] EWCA Civ. 1. [read post]
23 Jul 2019, 8:35 am
Brian Corderyby Nadine Bleach The Court of Appeal, overturning Birss J’s decision, decided that in the case of TQ Delta v ZyXEL, the answer was no. [read post]
27 Mar 2019, 5:28 am
Brian Cordery and Claire Phipps-JonesThe UK Supreme Court today handed down its decision in Actavis v ICOS. [read post]
4 Mar 2019, 8:44 am
Lilly v Genentech provided Arnold J will the opportunity to consider this issue in the context of two claims of Genentech’s patent to IL-17A/F antibodies. [read post]
5 Feb 2019, 1:19 am
Whether this is sufficient is at least questionable (especially in cases of a concurrent participation in rebate schemes in light of the Pregabalin-decision). [read post]
3 Jan 2019, 5:21 am
This same position was also taken by the EFTA Court in Pharmaq v. [read post]
20 Dec 2018, 6:09 am
Before actually dealing with Teva, he walked the audience through Medeva, Actavis v Sanofi (C-443/12) as well as Eli Lilly v HGS (C-493/12) (both judgments issued on 12 December 2013). [read post]
10 Dec 2018, 11:43 pm
The question at hand – and, I would say similar constitutional questions as well – should therefore be examined in the light of the EU Treaties taken as a whole. [read post]
6 Nov 2018, 9:11 am
Cease, for Brian Lang Tran, Appellant. [read post]
6 Aug 2018, 8:38 pm
Consider the role of fiduciary duty and monitoring and due diligence obligations of enterprises in light of changing jurisprudence. [read post]
26 Jun 2018, 8:59 am
In light of the reluctance of courts to impair the sanctity of contracts or vested rights, Royston, Rayzor, Vickery, & Williams, LLP v. [read post]
5 Aug 2017, 5:37 pm
Consider the role of fiduciary duty and monitoring and due diligence obligations of enterprises in light of changing jurisprudence. [read post]
